Evidence map›Paper›PMID 25898894›Full record

ArticleClinical oral investigations2015

In vitro treatment of Candida albicans biofilms on denture base material with volume dielectric barrier discharge plasma (VDBD) compared with common chemical antiseptics.

Rutger Matthes, Lukasz Jablonowski, Ina Koban, Antje Quade, Nils-Olaf Hübner, Rabea Schlueter, Klaus-Dieter Weltmann, Thomas von Woedtke, Axel Kramer, Thomas Kocher

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Cold Plasma Treatment forJournal of lasers in medical sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rutger MatthesUnit of Periodontology, Dental School, University of Greifswald, Rotgerberstr. 8, 17475, Greifswald, Germany. rutger.matthes@uni-greifswald.de.
Lukasz JablonowskiUnit of Periodontology, Dental School, University of Greifswald, Rotgerberstr. 8, 17475, Greifswald, Germany.
Ina KobanUnit of Periodontology, Dental School, University of Greifswald, Rotgerberstr. 8, 17475, Greifswald, Germany.
Antje QuadeLeibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany.
Nils-Olaf HübnerInstitute of Hygiene and Environmental Medicine, University Medicine Greifswald, Walther-Rathenau-Str. 49 a, 17475, Greifswald, Germany.
Rabea SchlueterInstitute of Microbiology, University of Greifswald, Friedrich-Ludwig-Jahn-Str. 15, 17487, Greifswald, Germany.
Klaus-Dieter WeltmannLeibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany.
Thomas von WoedtkeLeibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany.
Axel KramerInstitute of Hygiene and Environmental Medicine, University Medicine Greifswald, Walther-Rathenau-Str. 49 a, 17475, Greifswald, Germany.
Thomas KocherUnit of Periodontology, Dental School, University of Greifswald, Rotgerberstr. 8, 17475, Greifswald, Germany.
Leibniz Institute for Plasma Science and Technology · DEUniversität Greifswald · DEUniversitätsmedizin Greifswald · DEMicromun · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo prevent oral candidiasis, it is crucial to inactivate Candida-based biofilms on dentures. Common denture cleansing solutions cannot sufficiently inactivate Candida albicans. Therefore, we investigated the anticandidal efficacy of a physical plasma against C. albicans biofilms in vitro. MATERIALS AND

methodsArgon or argon plasma with 1 % oxygen admixture was applied on C. albicans biofilms grown for 2, 7, or 16 days on polymethylmethacrylate discs; 0.1 % chlorhexidine digluconate (CHX) and 0.6 % sodium hypochlorite (NaOCl) solutions served as positive treatment controls. In addition, these two solutions were applied in combination with plasma for 30 min to assess potential synergistic effects. The anticandidal efficacy was determined by the number of colony forming units (CFU) in log(10) and expressed as reduction factor (RF, the difference between control and treated specimen).

resultsOn 2-day-biofilms, plasma treatment alone or combined with 30 min CHX treatment led to significant differences of means of CFU (RF = 4.2 and RF = 4.3), clearly superior to CHX treatment alone (RF = 0.6). Plasma treatment of 7-day-or 16-day-old biofilms revealed no significant CFU reduction. The treatment of 7-day-old (RF = 1.7) and 16-day-old (RF = 1.3) biofilms was slightly more effective with NaOCl alone than with the combined treatment of NaOCl and plasma (RF = 1.6/RF = 1.9). The combination of CHX and plasma increased the RF immaterially.

conclusionThe use of plasma alone and in combination with antiseptics is promising anticandidal regimens for daily use on dentures when biofilms are not older than 2 days. CLINICAL RELEVANCE: Plasma could help to reduce denture-associated candidiasis.

Indexed as

Anti-Infective Agents, LocalBiofilmsCandida albicansChlorhexidineColony Count, MicrobialDenture BasesIn Vitro TechniquesPlasma GasesPolymethyl MethacrylateSodium HypochloriteTime FactorsAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconatePlasma GasesPolymethyl MethacrylateSodium HypochloriteCandida albicansChlorhexidineCold atmospheric pressure plasmaDentureIn vitro biofilmsSodium hypochloriteVolume dielectric barrier discharge (VDBD)

Identifiers

PMID25898894
OpenAlexW2053312520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.